Phacoemulsification with goniosynechialysis for nanophthalmos with secondary angle-closure or secondary angle-closure glaucoma: a 20-case series and stepwise management strategy - Takeaways - MDSpire

Phacoemulsification with goniosynechialysis for nanophthalmos with secondary angle-closure or secondary angle-closure glaucoma: a 20-case series and stepwise management strategy

  • By

  • Hongyan Zhu

  • Zuohong Wu

  • Yong Wang

  • Xun Zhan

  • Jin Lv

  • Li Ye

  • June 1, 2026

  • 0 min

Share

  • 1

    Nanophthalmos is a rare ocular condition associated with high hyperopia and a shallow anterior chamber, leading to complications like angle-closure glaucoma.

  • 2

    Phacoemulsification combined with goniosynechialysis (Phaco + IOL + GSL) is effective for managing angle-closure glaucoma in patients with nanophthalmos.

  • 3

    This study evaluated 20 patients with nanophthalmos and secondary angle-closure, demonstrating the feasibility and efficacy of the combined surgical approach.

  • 4

    Phaco + IOL + GSL offers a simpler technique and shorter operative time compared to more complex combined surgeries involving vitrectomy or sclerectomy.

  • 5

    The study proposes a stepwise management strategy for postoperative complications, enhancing the overall treatment approach for affected patients.

Original Source(s)

Phacoemulsification with goniosynechialysis for nanophthalmos with secondary angle-closure or secondary angle-closure glaucoma: a 20-case series and stepwise management strategy

  • by Hongyan Zhu, Zuohong Wu, Yong Wang, Xun Zhan, Jin Lv, Li Ye

  • June 1, 2026

Related Content

Combined phacoemulsification and angle filtering procedures versus phacoemulsification with clinical outcomes in primary glaucoma coexisting with cataracts: a meta-analysis of randomized controlled trials

Optegra Showcases Drop-Free Cataract Surgery Outcomes

Award-winning Optegra data on drop-free cataract surgery sparks interest at SECOIR 2026

  • June 11, 2026

  • 2 min
Rerouting Eye Care: How AI and Telemedicine Are Reshaping Ophthalmology Patient Journeys in the United Kingdom and Germany